HB 1796 · 2026 · House · Health, Human Services and Elderly Affairs Committee
Legalizing clinical psilocybin treatment
AI-generatedallowing the use of psilocybin in approved clinical settings to treat qualified medical conditions.
Allows the clinical use of psilocybin to treat qualified medical conditions, establishes a medical psilocybin program and regulatory board within the department of health and human services, and directs licensing of qualified providers.AI-generated
Status
Committee recommended Inexpedient to Legislate; died at adjournment · February 3, 2026- ✓Introduced
- ✕House
- Senate
- Governor
- Law
Analysis
This bill allows the use of psilocybin in approved clinical settings to treat qualified medical conditions. The bill establishes a medical psilocybin program and regulatory board in the department of health and human services and directs the department to license qualified providers.
From the bill's official ANALYSIS section.
In the bill's words
Quoted verbatim from the bill as introduced. Passages chosen from the operative text.Computed by this site
“"Board" means the psilocybin production establishment licensing board created pursuant to RSA 126-XX:7.”
“"Provider" means an approved medical or therapy provider licensed in this state who also holds a license from the department to recommend or provide services to qualified patients.”
“"Administration session" means services provided to a patient in an approved setting before, during, and after the ingestion of psilocybin and includes a preparation session, an administration session, and an integration session.”
“"Cultivation facility agent" means a person who has a permit from the department to grow and harvest or prepare psilocybin from psilocybin-producing mushrooms, including to compound, convert, process, or manufacture psilocybin products directly or indirectly from psilocybin mushrooms and to package or repackage or label or relabel the products.”
Official record
gc.nh.gov · the authoritative source
Sponsors
- Rep. Jennifer MandelbaumDClerk· State-Federal Relations and Veterans Affairs
- Rep. Tom MannionRAssistant Majority Whip
- Rep. Terry RoyRChair· Criminal Justice and Public Safety
- Sen. Howard PearlRChair· Executive Departments and Administration
Also: Rep. Henry GiassonR, Rep. Carol McGuireR, Rep. Matt Sabourin dit ChoinièreR, Sen. David WattersD
Public testimony
9 signed in online · 2 wrote testimony
44% support56% oppose0% neutral
In their wordsVerbatim, exactly as submitted
“The research is promising on the versatility and effectiveness of this treatment on so many human struggles from mental health to addiction to depression.”
“The verdict is still out on any therapeutic value from magic mushrooms, It is premature to establish a NH psilocybin program at this time.”
Verbatim excerpts of submitted testimony, quoted from the testimony tool.
Read the testimony · as of Aug 12, 2026
Votes
yeanay- Jan 28, 2026HouseCommittee report· regular calendar: Inexpedient to Legislate11–7Overall61% yea
Hearings and debates
- Jan 14, 2026Public hearingHouse Health, Human Services and Elderly AffairsWatchnot located in the transcript — opens the full streamPublic Hearing
- Jan 28, 2026Public hearingHouse Health, Human Services and Elderly AffairsWatchnot located in the transcript — opens the full streamMajority Committee Report: Inexpedient to Legislate — roll call; Executive Session
Timestamps locate where this bill is taken up in the chamber's YouTube stream.
Legislative history
- Jan 7, 2026HouseIntroduced 01/07/2026 and referred to Health, Human Services and Elderly Affairs HJ 1 P. 36
- Jan 14, 2026HousePublic Hearing: 01/14/2026 02:00 pm GP 158
- Jan 28, 2026HouseExecutive Session: 01/28/2026 02:30 pm GP 158
- Jan 28, 2026HouseMajority Committee Report: Inexpedient to Legislate 01/28/2026 (Vote 11-7; RC) HC 10 P. 91
- Feb 3, 2026HouseMinority Committee Report: Ought to Pass
Coverage
No reporting linked yet.
Documents (PDF)
Bill text & amendments link direct to gc.nh.gov; committee reports stream from the state record.